News & Analysis as of

Draft Guidance › Biologics › Consolidated Appropriations Act (CAA)

Akin Gump Strauss Hauer & Feld LLP

FDA Announces Draft Guidance for Industry Regarding Accelerated Approval for Drugs and Biologics

Akin Gump Strauss Hauer & Feld LLP on

On December 5, 2024, FDA unveiled the draft guidance for industry regarding accelerated approval for drugs and biologics. This guidance provides additional information regarding the development of drugs and biologics to treat...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide